Evaluation of various dissolution media for predicting In vivo performance of class I and II drugs

Pharmaceutical Research

Volumn 15, Issue 5, 1998, Pages 698-705

  Galia, E ^a   Nicolaides, E ^b   Horter D ^a   Lobenberg R ^a   Reppas, C ^b   Dressman, J B ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Acetaminophen; Compendial media; Danazol; Dissolution; Ketoconazole; Mefenamic acid; Metoprolol; Milk; Physiological media

Indexed keywords

DANAZOL; DRUG VEHICLE; KETOCONAZOLE; MEFENAMIC ACID; METOPROLOL; PARACETAMOL;

ARTICLE; DRUG CLASSIFICATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SCREENING; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MILK; PRIORITY JOURNAL; STOMACH JUICE;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIFUNGAL AGENTS; ANTIHYPERTENSIVE AGENTS; CAPSULES; DANAZOL; ESTROGEN ANTAGONISTS; KETOCONAZOLE; MEFENAMIC ACID; METOPROLOL; MILK; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; WATER;

EID: 0031750861     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011910801212     Document Type: Article

References (36)

1. P. Smith. Combinatorial screening approaches for selection of development candidates - experiences within SmithKline Beecham. Fourth International Conference on Drug Absorption, Edinburgh, Scotland (1997).
2. G. L. Amidon, H. Lennernäs, V. P. Shah, and J. R. Crison. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:413-420 (1995).
3. A. Rudman and R. Wiliams. Center for Drug Evaluation and Research (CDER). Guidance for Industry. Immediate release solid oral dosage forms. Scale-up and post-approval changes: Chemistry, manufacturing and controls, in vitro dissolution testing, and in vivo bioequivalence documentation. FDA, Rockville, MD (1995).
4. J. B. Dressman, G. L. Amidon, C. Reppas, and V. P. Shah. Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms. Pharm. Res. 15:11-22 (1998).
5. E. Galia, E. Nicolaides, C. Reppas, and J. B. Dressman. New media discriminate dissolution properties of poorly soluble drugs. Pharm. Res. 13(Supplement):S-262 (1996).
6. The United States Pharmacopeia (USP 23). United States Pharmacopeial Convention, Inc., Rockville, MD (1995).
7. J. E. Fairbrother. Analytical Profiles of Drug Substances (Volume 3), Ed. K. Florey, Academic Press, New York, NY (1974).
8. D. B. Jack. Handbook of Clinical Pharmacokinetic Data, Macmillan Publishers Ltd, Houndmills, UK (1992).
9. The Merck Index (Eleventh Edition), Ed. S . Budavari, M.J. O'Neil, A. Smith, and P. E. Hechelman, Merck & Co., Inc., Rahway, NJ (1989).
10. H. Lennernäs, S. Nylander, and A. L. Ungell. Jejunal permeability: A comparison between the Ussing chamber technique and the single-pass perfusion in humans. Pharm. Res. 14:667-671 (1997).
11. L. J. Naylor, V. Bakatselou, N. Rodriguez-Hornedo, N. D. Weiner, and J. B. Dressman. Dissolution of steroids in bile salt solutions is modified by the presence of lecithin. Eur. J. Pharm. Biopharm. 41:346-353 (1995).
12. C. N. TenHoor, V. Bakatselou, and J. B. Dressman. Solubility of mefenamic acid under simulated fed-and fasted state conditions. Pharm. Res. 8:1203-1205 (1991).
13. T. K. Daneshmend and D. W. Warnock. Clinical pharmacokinetics of ketoconazole. Clin. Pharmacokin. 14:13-34 (1988).
14. S. D. Mithani, V. Bakatselou, C. N. TenHoor, and J. B. Dressman. Estimation of the increase in solubility of drugs as a function of bile salt concentration. Pharm. Res. 13:163-167 (1996).
15. G. Rekhi et al. Evaluation of in vitro release and in vivo absorption characteristics of four metoprolol tartrate IR tablet formulations. Pharm. Dev. Tech. 2:11-24 (1997).
16. V. Bakatselou. Dissolution of steroidal compounds at physiological bile salt concentrations. Doctoral Thesis, University of Michigan, Ann Arbor, MI (1990).
17. P. Walstra, and R. Jerness. Dairy Chemistry and Physics, Wiley-Interscience, New York, NY (1984).
18. J. A. Clements, R. C. Heading, W. S. Nimmo, and L. F. Prescott. Kinetics of acetaminophen absorption and gastric emptying in man. Clin. Pharmacol. Ther. 24:420-431 (1978).
19. I. J. McGilveray and G. L. Mattok. Some factors affecting the absorption of paracetamol. J. Pharm. Pharmacol. 24:615-619 (1972).
20. M. Siewert. FIP guidelines for dissolution testing of solid oral products. Pharm. Ind. 59:760-766 (1997).
21. W. Brener, T. R. Hendrix, and P. R. McHugh. Regulation of the gastric emptying of glucose. Gastroenterol. 85:76-82 (1983).
22. V. P. Shah, J. J. Konecny, R. L. Everett, B. McCullough, A. C. Nooriazadeh, and J. P. Skelly. In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants. Pharm. Res. 6:612-618 (1989).
23. R. G. Crounse. Effective use of griseofulvin. Arch. Dermat. 87:176-180 (1963).
24. T. Bates, M. Gibaldi, and J. Kanig. Solubilizing properties of bile salt solutions. J. Pharm Sci. 55:191-199 (1966).
25. J. H. deSmidt, M. Grit, and D. J. A. Crommelin. Dissolution kinetics of griseofulvin in mixed micellar solutions. J. Pharm. Sci. 83:1209-1212 (1994).
26. W. N. Charman, M. C. Rogge, A. W. Boddy, W. H. Barr, and B. M. Berger. Absorption of danazol after administration to different sites of the gastrointestinal tract and the relationship to single-and double-peak phenomena in the plasma profiles. J. Clin. Pharmacol. 33:1207-1213 (1993).
27. L. J. Naylor. Comparison of the mechanism of dissolution of hydrocortisone in simple and mixed micelle systems. Doctoral Thesis, University of Michigan, Ann Arbor, MI (1993).
28. T. Hamaguchi, D. Shinkuma, Y. Yamanaka, and N. Mizuno. Bioavailability of mefenamic acid: Influence of food and water intake. J. Pharm. Sci. 75:891-893 (1986).
29. C. Reppas, G. Eleftheriou, J. B. Dressman, P. Macheras, and M. Symillides. The effect of elevated viscosity in the upper gastrointestinal tract on drug absorption in dogs. Eur. J. Pharm. Sci. (in press).
30. L. C. Dermentzoglou. Changes in upper gastrointestinal pH with aging: Implications for drug absorption. Doctoral Thesis, University of Michigan, Ann Arbor, MI (1989).
31. E. J. Randinitis and A. W. Kinkel. Bioequivalence comparison of mefenamic acid and soluble salts in dog, monkey and human. Personal Communication (1995).
32. J. B. Dressman, R. R. Berardi, L. C. Dermentzoglou, T. L. Russell, S. P. Schmaltz, J. L. Barnett, and K. M. Jarvenpaa. Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm. Res. 7:756-761 (1990).
33. J. W. M. van der Meer, J. J. Keuning, H. W. Scheijgrond, J. Heykants, and J. van Cutsem. Influence of gastric acidity on the bioavailability of ketoconazole. J. Antimicro. 6:520-524 (1980).
34. T. K. Daneshmend, D. W. Warnock, M. D. Ene, E. M. Johnson, and G. Parker. Influence of food on the pharmacokinetics of ketoconazole. J. Antim. Ag. Ch. 25: 1-3 (1984).
35. T. L. Russell, R. R. Berardi, J. L. Barnett, T. L. O'Sullivan, J. G. Wagner, and J. B. Dressman. pH-related changes in the absorption of dipyridamole in the elderly. Pharm. Res. 11:136-143 (1994).
36. S. Mithani. Dissolution and precipitation of dipyridamole: Effect of pH and bile salt concentration. Personal Communication (1997).